drugset / Trial / NCT01090895

Treatment of Reperfusion Event by Vitamin C Infusion

NCT01090895

Phase 4 Unknown 80 enrolled University of Roma La Sapienza
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary Hypothesis: Prophylactic Vitamin C Intravenous Infusion at the time of percutaneous coronary intervention (PCI) would limit the size of the infarct, assessed by measurements of cardiac biomarkers, during acute myocardial infarction. Secondary Hypotheses: Prophylactic Vitamin C Intravenous Infusion at the time of percutaneous coronary intervention (PCI) would limit the size of the infarct, as measured by the area of delayed hyperenhancement that was seen on cardiac magnetic resonance imaging (MRI), assessed on day 5 after infarction, during acute myocardial infarction.

Timeline

Start
2010-03
Primary completion
2017-10
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin C Other / unclassified 1 g Intravenous